24
Participants
Start Date
October 1, 2018
Primary Completion Date
September 15, 2021
Study Completion Date
December 2, 2021
89Zr-avelumab PET
89Zr-avelumab injection followed by 89Zr-Avelumab PET scan
Avelumab
"Early stage disease (stage Ia (≥T1b tumor)-IIIa: neo-adjuvant avelumab treatment (10mg/kg iv q2w) for a maximum duration of 2 cycles after PET-imaging, followed by surgical resection of the tumor with curative intent~Stage IIIb-IV disease: systemic treatment with avelumab 10mg/kg iv q2w after PET-imaging"
Radboud University, Nijmegen
Merck KGaA, Darmstadt, Germany
INDUSTRY
Radboud University Medical Center
OTHER